GSK-2330811
- Generic Name
- GSK-2330811
Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease
- First Posted Date
- 2019-11-05
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT04151225
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants
- First Posted Date
- 2019-10-24
- Last Posted Date
- 2021-05-24
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 9
- Registration Number
- NCT04138043
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
- First Posted Date
- 2017-02-02
- Last Posted Date
- 2021-05-24
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 35
- Registration Number
- NCT03041025
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 41
- Registration Number
- NCT02386436
- Locations
- 🇬🇧
GSK Investigational Site, Cambridge, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath